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A new article in this issue of Neuron (Pineda et al.,
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G proteins (Gi) in the control of AC activity in learningL., et al. (2000). Neuron 25, 533–535.
and memory. By eliminating Gi activity through pertussisHatakeyama, S., Wakamori, M., Ino, M., Miyamoto, N., Takahashi,
toxin injection, genetic knockout, or antisense oligonu-E., Yoshinaga, T., Sawada, K., Imoto, K., Tanaka, I., Yoshizawa, T.,
et al. (2001). Neuroreport 12, 2423–2427. cleotides treatment, Victor Pineda and colleagues show
Previews
5
that a selective decrease in Gi increases cAMP signaling
and enhances synaptic plasticity while impairing certain
forms of memory. Specifically, the inhibition of Gi by
pertussis toxin in area CA1 of the hippocampus is shown
to perturb passive avoidance and long-term memory for
contextual information. Interestingly, this effect was spe-
cific to area CA1 and did not occur when Gi was blocked
in CA3. The negative impact of Gi blockade was con-
firmed by disruption of one or two copies of the Gi
gene in knockout mice. This genetic manipulation also
impaired long-term retention of information on the pas-
sive avoidance and object recognition test. However,
it did not perturb spatial learning and memory or the
acquisition and the extinction of cued fear conditioning,
suggesting a selective effect of Gi disruption on some,
but not all, forms of memory. Contrary to its inhibitory
effect on memory, however, lack of Gi facilitated syn-
aptic plasticity and prolonged long-term potentiation
(LTP). It turned a decremental form of LTP into a robust
PKA- and protein synthesis-dependent form, indicating Figure 1. The Activation of G Protein-Responsive Transmembrane
that an increase in cAMP strengthens synaptic plasticity. AC by Gs and Their Inhibition by Gi Control the Level of cAMP
These results are novel in that they demonstrate the and the Recruitment of Downstream Effectors
existence of a tonic inhibitory constraint applied by Gi on Abbreviations: AC, adenylyl cyclase; CNG, cyclic nucleotide gated;
cAMP production in the context of learning and memory. Epac, exchange protein activated by cAMP; PDE, phosphodies-
terase.cAMP is therefore not only modulated by PDE-mediated
degradation, but also by restraint on its synthesis via
ACs. This inhibitory constraint seems to complement in the transduction of sensory signals. cAMP also con-
and not simply duplicate the action of PDE-dependent trols a newly identified family of proteins, the Epacs
mechanisms because inactivating Gi or PDEs appears (exchange protein directly activated by cAMP) (Bos,
to have a different impact on cAMP signaling and learn- 2003). Epacs contain domains homologous to the gua-
ing and memory. Thus, spatial learning is altered by nine nucleotide exchange factors (GEFs), and cAMP-
PDE1B knockout while it is intact in the Gi mutant mice regulated GEFs selectively activate the Ras superfamily
(Reed et al., 2002). Further, the inhibition of PDE4 by of small G proteins, Rap1 and Rap2. They can therefore
specific antagonists improves rather than impairs learn- initiate active cross-talk between the cAMP and the Ras/
ing and memory (Barad et al., 1998; Bourtchouladze et mitogen-activated protein kinase (MAPK) pathways,
al., 2003). These discrepant results suggest that PDEs providing an additional layer in cAMP signaling. Several
PDEs are known as well to be activated by cAMP andmay be differentially involved in learning and memory,
similar to ACs, which are known to be distinctly regu- thereby contribute to the homeostatic regulation of
cAMP. This diversity of targets makes cAMP a pleiotro-lated in specific brain areas depending on the type of
learning (Guillou et al., 1999; Mons et al., 2003). Such pic messenger whose action is therefore not limited to
the control of PKA activity as initially thought (Figure 1).specificity may partly account for the different impact of
Gi inactivation in CA1 versus CA3, or on hippocampus- Differential modulation of these targets may explain the
divergent phenotypes observed in the various pharma-dependent versus -independent memory in the Gi mu-
tant mice. cological and genetic mouse models.
Finally, the Gi mutant mice add to the list of mouseHowever, the divergent impact of cAMP modulation
in the different models could also be explained by a models in which opposite effects on memory and plas-
ticity are observed. The most recent examples of a dis-disparity in the extent, localization, or duration of the
increase in cAMP. Quantitatively, it is recognized that sociation between memory/LTP phenotypes are mice
lacking tropomodulin-2, syndecan-3, or Fmr2 in whichoptimal levels of cAMP are required for efficient learning
and memory. While a mild increase in cAMP may en- LTP is enhanced but learning and memory are impaired
(Gu et al., 2002; Cox et al., 2003; Kaksonen et al., 2003).hance performance, a large increase may impair it. Fur-
ther, the cellular compartment in which cAMP is re- Additional examples include mice with enhanced LTP
but normal learning and memory (Jun et al., 1998) orleased is of prime importance as it determines which
downstream effectors are activated. Since cAMP has a mice with defective plasticity but improved learning
(Collinson et al., 2002). Rather than shadowing the po-low diffusion rate (1 m) due to its compartmentaliza-
tion, a change in its synthesis by local G protein-depen- tential link between synaptic plasticity and memory,
such dissociation highlights the existence of multipledent transmembrane ACs is likely to affect mostly tar-
gets near or at the membrane. Many cAMP-dependent forms of LTP whose relevance is likely specific to certain
forms of learning and memory. The physiological envi-and cAMP binding effectors have been identified, and
recently, several alternative and unconventional path- ronment during LTP recordings is also important, and
LTP measures in the intact animal may best revealways have been discovered. For instance, direct cAMP
binding is now known to regulate cyclic nucleotide- changes correlating with behavior. Additional forms of
plasticity like LTD and depotentiation may also be rel-gated (CNG) channels such as pacemaker voltage-
gated potassium channels or other channels involved evant.
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In summary, great progress has been made in the
understanding of cell signaling since the first discoveries
of cAMP by Earl Sutherland and of G proteins and their
role in signal transduction by Alfred Gilman and Martin
Rodbell. Much progress still remains to be made, how-
ever, to fully uncover the mechanisms of cAMP-medi-
ated pathways, a step that is essential to the elucidation
of many brain pathologies.
Isabelle Mansuy
Institute of Cell Biology
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